Immunoblot analysis of antibody responses to Sporothrix schenckii
- PMID: 2915023
- PMCID: PMC267296
- DOI: 10.1128/jcm.27.2.300-304.1989
Immunoblot analysis of antibody responses to Sporothrix schenckii
Abstract
The serologic response to Sporothrix schenckii was investigated in patients with sporotrichosis by solid-phase enzyme-linked immunosorbent assays (ELISAs) and Western immunoblot techniques. A soluble antigen preparation derived from an S. schenckii isolate contained 15 protein staining components ranging in molecular size from 22 to 70 kilodaltons (kDa) by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Sera from 40 patients with sporotrichosis demonstrated Sporothrix immunoglobulin G antibody by ELISA with titers between 128 and 65,200. No sera from 300 healthy individuals or 100 patients with various systemic mycoses other than sporotrichosis had ELISA titers greater than 64. By Western immunoblotting of the antigens separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, sera from 10 patients with cutaneous sporotrichosis reacted with 8 to 10 antigen components (range, 40 to 70 kDa), while sera from 15 patients with extracutaneous sporotrichosis reacted with a greater number of antigen components (15 to 20 bands) over a wider range of molecular sizes (22 to 70 kDa). Antibody to 40- and 70-kDa antigen components was detected by immunoblots in all sera tested from patients with sporotrichosis. Antibody to 22- to 36-kDa antigen components was present in sera from 13 of 15 patients with extracutaneous sporotrichosis, but these lower-molecular-weight components were not detected by sera from patients with cutaneous sporotrichosis. Antibody to these components was not detected by Western blotting in sera from 19 of 20 patients with other fungal diseases or from 30 healthy individuals. Purification of these specific antigen fractions could provide the basis of a sensitive and specific serodiagnostic test to indicate the presence and activity of extracutaneous sporotrichosis.
Similar articles
-
Proteomics-Based Characterization of the Humoral Immune Response in Sporotrichosis: Toward Discovery of Potential Diagnostic and Vaccine Antigens.PLoS Negl Trop Dis. 2015 Aug 25;9(8):e0004016. doi: 10.1371/journal.pntd.0004016. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26305691 Free PMC article.
-
[Serology of cutaneous sporotrichosis].Sabouraudia. 1983 Dec;21(4):317-21. Sabouraudia. 1983. PMID: 6419354 Spanish.
-
Use of mycelial-phase Sporothrix schenckii exoantigens in an enzyme-linked immunosorbent assay for diagnosis of sporotrichosis by antibody detection.Clin Vaccine Immunol. 2007 Mar;14(3):244-9. doi: 10.1128/CVI.00430-06. Epub 2007 Jan 10. Clin Vaccine Immunol. 2007. PMID: 17215334 Free PMC article.
-
Molecular identification of the Sporothrix schenckii complex.Rev Iberoam Micol. 2014 Jan-Mar;31(1):2-6. doi: 10.1016/j.riam.2013.09.008. Epub 2013 Nov 19. Rev Iberoam Micol. 2014. PMID: 24270070 Review.
-
Cell wall proteins of Sporothrix schenckii as immunoprotective agents.Rev Iberoam Micol. 2014 Jan-Mar;31(1):86-9. doi: 10.1016/j.riam.2013.09.017. Epub 2013 Nov 17. Rev Iberoam Micol. 2014. PMID: 24257472 Review.
Cited by
-
Proteomics-Based Characterization of the Humoral Immune Response in Sporotrichosis: Toward Discovery of Potential Diagnostic and Vaccine Antigens.PLoS Negl Trop Dis. 2015 Aug 25;9(8):e0004016. doi: 10.1371/journal.pntd.0004016. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26305691 Free PMC article.
-
Characterization of the cellular antigens of Paracoccidioides brasiliensis yeast form.J Clin Microbiol. 1990 Jun;28(6):1188-93. doi: 10.1128/jcm.28.6.1188-1193.1990. J Clin Microbiol. 1990. PMID: 2380351 Free PMC article.
-
Host organism defense by a peptide-polysaccharide extracted from the fungus Sporothrix schenckii.Mycopathologia. 1998-1999;144(1):9-14. doi: 10.1023/a:1006964516334. Mycopathologia. 1998. PMID: 10422268
-
Sporotrichosis: a Comprehensive Review on Recent Drug-Based Therapeutics and Management.Curr Dermatol Rep. 2022;11(2):110-119. doi: 10.1007/s13671-022-00358-5. Epub 2022 Mar 17. Curr Dermatol Rep. 2022. PMID: 35313686 Free PMC article. Review.
-
Vaccine development for pathogenic fungi: current status and future directions.Expert Rev Vaccines. 2023 Jan-Dec;22(1):1136-1153. doi: 10.1080/14760584.2023.2279570. Epub 2023 Nov 13. Expert Rev Vaccines. 2023. PMID: 37936254 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources